Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cabozantinib in Advanced or Metastatic Cervical Carcinoma After Platinum Treatment Failure
NCT04205799Phase 2Completed
- Sponsor
- Centre François Baclesse
- Start
- Jan 2020
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cabozantinib in Cervical Cancer (CC), sponsored by Centre François Baclesse. Started Jan 2020; status: completed.
02
Drugs
cabozantinib
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT04205799.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04205799.